| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13G · 4 securities · passive | ||||||
|
ADARx Pharmaceuticals, Inc.
13G
ADRX · 00654F105
|
6.3% |
10/1/2026
Event 9/24/2026
|
||||
|
Heartflow, Inc.
13G/A
HTFL · 42238D107
|
9.8% |
8/14/2026
Event 6/30/2026
|
||||
|
Cidara Therapeutics, Inc.
13G/A
CDTX · 171757206
|
0% |
2/17/2026
Event 12/31/2025
|
||||
|
Dianthus Therapeutics, Inc.
13G/A
DNTH · 252828108
|
3.1% |
11/14/2025
Event 9/30/2025
|
||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.